Overview

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

Status:
Completed
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
This is a Phase 2 randomized, double-blind, parallel group, vehicle-controlled study to evaluate the safety and efficacy of topical ATx201 OINTMENT in adolescents and adults with mild to moderate Atopic Dermatitis
Phase:
Phase 2
Details
Lead Sponsor:
UNION therapeutics